Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Dec 2018 – 20 Aug 2026, limited by DSP Healthcare Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | DSP Healthcare Fund | Nifty 500 |
|---|---|---|
| 03 Dec 2018 | ₹100.00 | ₹100.00 |
| 26 Jul 2019 | ₹100.35 | ₹100.72 |
| 17 Mar 2020 | ₹106.76 | ₹81.27 |
| 06 Nov 2020 | ₹175.99 | ₹109.93 |
| 29 Jun 2021 | ₹194.38 | ₹147.72 |
| 19 Feb 2022 | ₹191.11 | ₹161.18 |
| 12 Oct 2022 | ₹168.37 | ₹162.49 |
| 03 Jun 2023 | ₹169.17 | ₹173.24 |
| 24 Jan 2024 | ₹230.75 | ₹213.12 |
| 15 Sep 2024 | ₹279.45 | ₹262.17 |
| 08 May 2025 | ₹229.06 | ₹239.33 |
| 28 Dec 2025 | ₹245.82 | ₹260.55 |
| 20 Aug 2026 | ₹263.68 | ₹257.62 |
| Metric | DSP · Regular · IDCW NAV ₹26.51 Very High risk ★★★☆☆ | Category median Sectoral/ Thematic · 248 funds |
|---|---|---|
| +5.71% | +3.54% | |
| +10.96% | +11.47% | |
| +5.22% | +9.70% | |
| — | +10.32% | |
| +13.40% | +9.15% | |
| +9.48% | — | |
| +12.21% | +12.10% | |
| +12.82% | +10.32% | |
| — | +8.80% | |
| Risk | ||
| 15.61% | 15.91% | |
| 0.29 | 0.25 | |
| 0.35 | 0.32 | |
| -29.53% | -26.14% | |
| Nifty 500 | — | |
| +1.23% | -0.04% | |
| 0.80 | 0.98 | |
| 81.0% | 98.3% | |
| 70.8% | 101.5% | |
| 2.04% | 2.38% | |
| ₹3,218Cr | ₹1,160Cr | |
| Up to 0.50% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 67% | 42% | |
| Chirag Dagli | — | |
| 03 Dec 2018 | — | |
| 23 | — | |
| 56.9% | — | |
| 6.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.